Introduction
Cholesterol is suggested to increase the risk of Alzheimer's disease (Kivipelto et al., 2001; Pappolla et al., 2003; Wolozin 2004) and has been shown in animal and cellular models to increase the production of β-amyloid (Aβ) peptide (Sparks et al., 1994; Refolo et al., 2000; Shie et al., 2002; Racchi et al., 1997; Simons et al., 1998; Austen et al., 2003; Frears et al., 1999) , a major pathological hallmark of Alzheimer's disease. There is also evidence that cholesterol co-localizes with fibrillar Aβ in the amyloid plaques of transgenic mice (Burns et al., 2003) . Despite the large number of studies linking cholesterol to Aβ production, the mechanisms by which cholesterol increases Aβ levels are still to be determined. Cholesterol homeostasis in the brain is regulated through de novo synthesis, with no or very poor transfer from the peripheral circulation due to the impermeability of the BBB to the lipoproteins that carry cholesterol (Lange et al., 1999) . In contrast to cholesterol, 27-hydroxycholesterol, a product of cholesterol oxidation (oxysterol), has been shown to cross the BBB into the brain (Heverin et al., 2005) . It may be possible that increased entrance of this oxysterol into the brain following hypercholesterolemia places the brain at risk for neurodegeneration.
Evidence suggests that IGF-1, a neurotrophic factor that promotes neurogenesis and has neuroprotective effects, plays an important role in regulating Aβ peptide levels (Costantini et al., 2006; Puglielli 2008) . The IGF-1 signaling involves the binding of IGF-1 to its receptor, IGF-1R, thereby activating protein kinase B (Akt) through phosphorylation. Phosphorylated Akt (p-Akt) modulates IDE expression (Zhao et al., 2004) and regulates the phosphorylation of GSK-3α and β. IDE is a major Aβ-degrading enzyme (Kurochkin and Goto 1994; Farris et al., 2004) due to its ability to cleave the Leu16-Leu17 bond within the Aβ region of the β-APP (Bernstein et al., 1999) . The GSK-3α enzyme has been demonstrated to be required for the maximal processing of β-APP and subsequent Aβ production (Phiel et al., 2003) . Similarly to GSK-3α, GSK-3β isoform is also an IGF-1 downstream-regulated protein, but is involved in the phosphorylation of tau protein as well as the transcriptional factor cAMP responsive element-binding protein (CREB). While hyperphosphorylation of tau can lead to neurofibrillary tangle formation, phosphorylated CREB (p-CREB) can promote cell survival by up-regulating the expression of the anti-apoptotic proteins Bcl-2 (Ji et al., 1996; Riccio et al., 1999) .
Currently, the effect of cholesterol or 27-hydroxycholesterol on IGF-1, IDE, GSK-3α/β, CREB, and Bcl-2 levels and the extent to which changes in levels of these proteins are associated with increased Aβ levels are not clear. The aim of this work was to determine the effect of a cholesterol-enriched diet and 27-hydroxycholesterol on the IGF-1 signaling pathway in rabbit hippocampus. Results of our work would add important insights into the cellular mechanisms by which high Neurobiology of Disease 32 (2008) [426] [427] [428] [429] [430] [431] [432] 
